AzurRx (AZRX) Corporate Media Kit

14 4480mg + Enteric Capsule In vitro Animal Studies Rats 4700 mg/kg/day Mini-Pigs 1175 mg/kg/day Phase I CP 180mg Phase II CP 280mg 560mg 1120mg 2240mg Phase IIa CF 2240mg Phase IIb CF 2240mg + Enteric Capsule Phase III CF* 2240mg or 4480mg + Enteric Capsule Monotherapy Combination Therapy Phase II CF Daily Dose PERT + 700mg 1120mg 2240mg * Based on results of Phase IIb clinical trial Completed Ongoing MS1819 Clinical Pathway Ongoing Phase 2 CF Trials to Determine Optimal Dose